Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beer

Showing results (801-810 of 888) with videos related to

Pageof 89
Sort By:
Nature Communications|November 28, 2018
Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapyHao Geng, Changhui Xue, Janet Mendonca, et al.
Transboundary and Emerging Diseases|November 11, 2017
Rapid and simple detection of foot-and-mouth disease virus: Evaluation of a cartridge-based molecular detection system for use in basic laboratoriesK V Goller, V Dill, M Madi, et al.
Plos One|September 9, 2014
Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomesRyan R Gordon, Mengchu Wu, Chung-Ying Huang, et al.
JCO Precision Oncology|October 26, 2019
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision MakingDerrick L Tao, Shawna Bailey, Tomasz M Beer, et al.
The Oncologist|May 11, 2026
A Phase I/II Trial of Concurrent Chemo-hormonal Enzalutamide and Cabazitaxel in Patients with Metastatic Castration-Resistant Prostate CancerJulie N Graff, Claire E P Smith, Alexandra O Sokolova, et al.
Clinical Genitourinary Cancer|February 21, 2012
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancerMark T Fleming, Guru Sonpavde, Michael Kolodziej, et al.
Transboundary and Emerging Diseases|March 10, 2009
Epidemiological and ornithological aspects of outbreaks of highly pathogenic avian influenza virus H5N1 of Asian lineage in wild birds in Germany, 2006 and 2007A Globig, C Staubach, M Beer, et al.
American Journal of Ophthalmology|November 5, 2003
Acute endophthalmitis following intravitreal triamcinolone acetonide injectionDarius M Moshfeghi, Peter K Kaiser, Ingrid U Scott, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 5, 2024
Outcomes following a false positive multi-cancer early detection (MCED) test: Results from DETECT-A, the first large, prospective, interventional MCED studyAnne Marie Lennon, Adam H Buchanan, Seema P Rego, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 10, 2024
Outcomes Following a False-Positive Multi-Cancer Early Detection Test: Results from DETECT-A, the First Large, Prospective, Interventional MCED StudyAnne M Lennon, Adam H Buchanan, Seema P Rego, et al.
Pageof 89

Showing results (801-810 of 888) with videos related to

Sort By:
Pageof 89
Nature Communications|November 28, 2018
Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen/AR-targeted therapyHao Geng, Changhui Xue, Janet Mendonca, et al.
Transboundary and Emerging Diseases|November 11, 2017
Rapid and simple detection of foot-and-mouth disease virus: Evaluation of a cartridge-based molecular detection system for use in basic laboratoriesK V Goller, V Dill, M Madi, et al.
Plos One|September 9, 2014
Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomesRyan R Gordon, Mengchu Wu, Chung-Ying Huang, et al.
JCO Precision Oncology|October 26, 2019
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision MakingDerrick L Tao, Shawna Bailey, Tomasz M Beer, et al.
The Oncologist|May 11, 2026
A Phase I/II Trial of Concurrent Chemo-hormonal Enzalutamide and Cabazitaxel in Patients with Metastatic Castration-Resistant Prostate CancerJulie N Graff, Claire E P Smith, Alexandra O Sokolova, et al.
Clinical Genitourinary Cancer|February 21, 2012
Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancerMark T Fleming, Guru Sonpavde, Michael Kolodziej, et al.
Transboundary and Emerging Diseases|March 10, 2009
Epidemiological and ornithological aspects of outbreaks of highly pathogenic avian influenza virus H5N1 of Asian lineage in wild birds in Germany, 2006 and 2007A Globig, C Staubach, M Beer, et al.
American Journal of Ophthalmology|November 5, 2003
Acute endophthalmitis following intravitreal triamcinolone acetonide injectionDarius M Moshfeghi, Peter K Kaiser, Ingrid U Scott, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 5, 2024
Outcomes following a false positive multi-cancer early detection (MCED) test: Results from DETECT-A, the first large, prospective, interventional MCED studyAnne Marie Lennon, Adam H Buchanan, Seema P Rego, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 10, 2024
Outcomes Following a False-Positive Multi-Cancer Early Detection Test: Results from DETECT-A, the First Large, Prospective, Interventional MCED StudyAnne M Lennon, Adam H Buchanan, Seema P Rego, et al.
Pageof 89